Back to today’s briefing

Story perspectives

HIV Drug Market Set to Surge to $2.16 Billion

1/17/2025

35 3

Summary

Story summary

The global HIV drugs market is on the rise, expected to soar from USD 1.65 billion in 2023 to USD 2.16 billion by 2032, fueled by a 3.90% growth rate. This surge is driven by heightened research and development investments and a growing number of HIV cases, with industry giants like Merck, AbbVie, and Gilead Sciences leading the charge in innovative antiretroviral therapies.

1 of 1

Story summary

The global HIV drugs market is on the rise, expected to soar from USD 1.65 billion in 2023 to USD 2.16 billion by 2032, fueled by a 3.90% growth rate. This surge is driven by heightened research and development investments and a growing number of HIV cases, with industry giants like Merck, AbbVie, and Gilead Sciences leading the charge in innovative antiretroviral therapies.